Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Filings indexed 1,418 across all filing types
Latest filing 2023-01-16 Declaration of Voting R…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, voting rights percentages, and details of instruments (options, swaps) held by a major shareholder (The Goldman Sachs Group, Inc.) in MorphoSys AG. This structure perfectly matches the definition of a notification regarding changes in significant share ownership thresholds, which corresponds to the Major Shareholding Notification category (MRQ). Although it is a regulatory announcement disseminated via EQS, the specific content dictates the classification over the general 'RNS' fallback.
2023-01-16 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed sections like 'Notification of Major Holdings', 'Details of issuer', 'Reason for notification' (specifically mentioning 'Acquisition/disposal of shares with voting rights'), and 'Total positions' detailing changes in voting rights percentages held by The Goldman Sachs Group, Inc. This structure perfectly matches the definition of a notification regarding changes in significant share ownership thresholds, which corresponds to the Major Shareholding Notification category (MRQ). Although it is a regulatory announcement disseminated via EQS, the specific content dictates the classification over the general 'RNS' fallback.
2023-01-13 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in voting rights percentages, acquisition/disposal of shares/instruments, and a breakdown of holdings by The Goldman Sachs Group, Inc. in MorphoSys AG, referencing specific sections of the German Securities Trading Act (WpHG). This content directly matches the definition of a notification regarding changes in significant share ownership thresholds, which corresponds to the Major Shareholding Notification category (MRQ). Although it is a regulatory announcement, MRQ is more specific than the general RNS fallback.
2023-01-12 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Notification of Major Holdings' and references German securities law (WpHG) regarding the 'Acquisition/disposal of shares with voting rights' and 'Change of breakdown of voting rights'. It details changes in voting rights percentages held by JPMorgan Chase & Co. and its subsidiaries, crossing specific thresholds (e.g., 3% and 5%). This type of mandatory disclosure regarding significant changes in share ownership by investors or insiders falls directly under the category of Major Shareholding Notification.
2023-01-10 English
Declaration of Voting Results & Voting Rights Announcements 2023
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is explicitly titled 'Voting Rights Announcements' and contains detailed tables reporting changes in share ownership, voting rights attached to shares, and rights through financial instruments (options, swaps) held by a major shareholder (The Goldman Sachs Group, Inc.). This structure perfectly matches the definition of a notification regarding changes in significant share ownership thresholds, which corresponds to the Major Shareholding Notification category (MRQ). Although it mentions 'Voting Rights Announcements' in the header, the content is a formal disclosure of holding percentages, which is the core function of an MRQ filing in many jurisdictions, distinct from the results of a general meeting (DVA).
2023-01-10 English
MorphoSys AG: MorphoSys Expects Topline Data from Phase 3 Study of Pelabresib in Myelofibrosis in Early 2024
Regulatory Filings Classification · 1% confidence The document is a news release dated January 9, 2023, announcing an update regarding the expected timeline for topline data from a Phase 3 clinical study (MANIFEST-2) for the drug Pelabresib. It also mentions that the CEO will provide further updates at the J.P. Morgan Healthcare Conference. The text is short (under 5,000 characters based on the provided snippet length, and the metadata confirms it's not a full report) and functions as a general corporate announcement disseminated via EQS News. Since it is not a full financial report (like 10-K or IR), nor a specific announcement like a dividend (DIV) or management change (MANG), and it is a general corporate update distributed through a news service, it best fits the Regulatory Filings (RNS) category, which serves as a general regulatory announcement fallback for non-standard filings.
2023-01-09 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.